Description

Brand Abbott

Influvac Tetra NH 2025/2026 0.5ml Pfs Injection is a quadrivalent influenza vaccine designed for active immunization against four prevalent influenza virus strains: two influenza A subtypes and two influenza B lineages. This vaccine is indicated for adults and children from 6 months of age and older, providing protection against seasonal influenza.

The vaccine is especially recommended for individuals at higher risk of severe influenza complications, including young children, elderly adults, pregnant women, and those with chronic health conditions such as diabetes, kidney disease, chronic obstructive pulmonary disease (COPD), or heart failure. It is administered as a 0.5ml dose by intramuscular or deep subcutaneous injection, with the intramuscular route being preferred. Typically, a single dose is given annually before the influenza season. For children less than 9 years of age who have not previously been vaccinated, a second 0.5ml dose is recommended after an interval of at least 4 weeks.

Key Features : 

Provides active immunization against four influenza virus strains, including two A subtypes and two B lineages, as recommended for the 2025/2026 Northern Hemisphere season.
Indicated for a broad target population, including adults and children from 6 months of age, particularly those at increased risk of complications.
Requires cold-chain storage at 2°C to 8°C and must not be frozen to maintain vaccine integrity.
Administered via intramuscular or deep subcutaneous injection, ensuring proper delivery by a qualified healthcare professional.
Complies with World Health Organisation (WHO) and European Union (EU) recommendations for the 2025/2026 influenza season.